| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/22/2004 | WO2003088892A3 Transportation of biological matter to a target site in a closed volume for transplantation purposes |
| 07/22/2004 | WO2003087303A3 Tissue composites and uses thereof |
| 07/22/2004 | WO2003077863A3 Method for overexpression of zwitterionic polysaccharides |
| 07/22/2004 | WO2003073916A3 Immune regulation |
| 07/22/2004 | WO2003062423A3 Method for inhibiting the expression of a target gene resulting from a chromosome aberration |
| 07/22/2004 | WO2003052078A3 Insect g protein-coupled receptor genes and uses thereof |
| 07/22/2004 | WO2003027253A3 Variants of alpha-fetoprotein coding and expression sequences |
| 07/22/2004 | WO2003022869A3 Human immunodeficiency virus envelope clycoprotein mutants and uses thereof |
| 07/22/2004 | WO2002101076A3 Methods for targeted expression of therapeutic nucleic acid |
| 07/22/2004 | WO2002099048A3 LIMKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 07/22/2004 | WO2002074239A3 Compositions and methods for the treatment and clinical remission of psoriasis |
| 07/22/2004 | WO2002059281A3 High level cytokine production with enhanced cell viability |
| 07/22/2004 | US20040143868 Root promoter sequences for use as gene expression tools in plants |
| 07/22/2004 | US20040143864 Chimeric gene constructs for generation of fluorescent transgenic ornamental fish |
| 07/22/2004 | US20040143863 Expression vectors comprising bone morphogenic protein for use in the transformation of osteoblast and controlling propagation and enrichment of stem cells in vivo |
| 07/22/2004 | US20040143862 Mammalian embryonic stem cell wherein the lecithin:cholesterol acyltransferase-like lysophospholipase gene is inactivated for use as model for identifying modulators for treatment of arteriosclerosis |
| 07/22/2004 | US20040143861 Using satellite artificial chromosome (SATAC) as gene therapeutic tool to transform and propagate transgenic cells and treat metabolic disorders |
| 07/22/2004 | US20040143859 Novel proteins and methods for producing the proteins |
| 07/22/2004 | US20040143857 Erythropoietin analog-human serum albumin fusion |
| 07/22/2004 | US20040143854 Using inducible vectors to transform cells and propagate organism for use as drug screening tools; phenotyping |
| 07/22/2004 | US20040143238 System and method for forming a non-ablative cardiac conduction block |
| 07/22/2004 | US20040143102 Ligand polypeptide for identifying modulators for treatment of nervous system disorders, schizophrenia and arthritis |
| 07/22/2004 | US20040142960 Yohimbine as immunobiologically active agent |
| 07/22/2004 | US20040142901 Production of pancreatic islet cells and delivery of insulin |
| 07/22/2004 | US20040142886 use of vascular endothelial growth factor to enhance smooth muscle cell proliferation and to treat diseases associated with reduced smooth muscle cell proliferation |
| 07/22/2004 | US20040142885 host cell; gene therapy |
| 07/22/2004 | US20040142861 at least one genetically-engineered growth factor, at least one genetically-engineered antioxidant, at least one genetically-engineered extracellular matrix component |
| 07/22/2004 | US20040142477 Expression vector comprising antisense or inhibitory RNA sequences for use in increasing phyotene concentration in plants; tissue engineering |
| 07/22/2004 | US20040142476 Organellar targeting of RNA and its use in the interruption of environmental gene flow |
| 07/22/2004 | US20040142472 Gene delivery vectors with cell type specificity for primary human chondrocytes |
| 07/22/2004 | US20040142468 Modulation of systemic immune responses by transplantation of hematopoietic stem cells transduced with genes encoding antigens and antigen presenting cell regulatory molecules |
| 07/22/2004 | US20040142467 Regeneration of both plant tissues and transgenic plant tissues using a new plant hormone, 5-bromoindole-3-acetic acid |
| 07/22/2004 | US20040142466 Extending tissue preservation |
| 07/22/2004 | US20040142465 Injectable hyaluronic acid derivative with pharmaceuticals/cells |
| 07/22/2004 | US20040142464 Transgenic human cells expressing superantigens/antiproliferative agents for use as gene therapeutic tools in cancer treatment ; tissue engineering |
| 07/22/2004 | US20040142463 Methods, compositions, and automated systems for separating rare cells from fluid samples |
| 07/22/2004 | US20040142462 Cell propagation apparatus comprising collapsible bag; bioreactors and tissue culture |
| 07/22/2004 | US20040142450 Swine respiratory system tissues for use as bioreactors for preparing influenzal viral particles for use in identification of viricides; tissue engineering and vaccine development |
| 07/22/2004 | US20040142432 Preparing single chain antibodies comprised of camelid subunits for treating and preventing inflammation, allergies, cancer, infections, transplant rejection, autoimmune and muscular disorders |
| 07/22/2004 | US20040142431 Nucleotide sequences comprising restriction fragment length polymorphisms coding polypeptide with antiproliferative, antiviral and antiparasitic effects |
| 07/22/2004 | US20040142430 Production of a multimeric protein by cell fusion method |
| 07/22/2004 | US20040142427 Nucleotide sequences coding lyase for use as tool in identifying treatments which prevent or inhibit tumor cell metastasis, inflammation and autoimmunity |
| 07/22/2004 | US20040142426 Novel proteins and methods for producing the proteins |
| 07/22/2004 | US20040142421 Pacemake ion channel proteins and uses thereof |
| 07/22/2004 | US20040142419 Reducing cellular dysfunction caused by mitochondrial gene mutations |
| 07/22/2004 | US20040142418 Novel neurotrophic factors |
| 07/22/2004 | US20040142417 Receptor proteins |
| 07/22/2004 | US20040142415 Comprises nucleotide sequences coding serum amyloid apolipoprotein-3 for use in treatment and prevent of enteric infections |
| 07/22/2004 | US20040142394 Method for diagnosing a tumor in a patient determining the concentration of PIBF |
| 07/22/2004 | US20040142391 Methods for determining whether a compound is capable of inhibiting the interaction of a peptide with RAGE |
| 07/22/2004 | US20040142376 Deoxyribonuclease IIbeta proteins and cDNAs |
| 07/22/2004 | US20040142368 Method of identifying therapeutic agents |
| 07/22/2004 | US20040142356 can be used to develop a mammalian bioluminescence bioreporter useful in various medical research and diagnostics applications; genetic engineering |
| 07/22/2004 | US20040142320 use of cells capable or carrying out a process of prenylation of proteins coded by the hepatitis C virus (HCV) genome for diagnosis/drug screening; antibiotic resistance |
| 07/22/2004 | US20040141995 MHC class I-restricted and MHC class II-restricted EBNA1 peptides |
| 07/22/2004 | US20040141979 isolation and production of cancerous disease modifying antibodies (CDMAB) and to the use of these CDMAB in therapeutic and diagnostic processes; anticancer agents |
| 07/22/2004 | US20040141967 Methods and compositions for treating macrophage-mediated diseases |
| 07/22/2004 | US20040141957 Culturing pancreatic stem cells having a specified, intermediate stage of development |
| 07/22/2004 | US20040141945 novel material which combines cell-adhesive proteins such as collagen with GAG polymers to construct an environment similar to an extracellular matrix, capable of controlling differentiation and proliferation of cells |
| 07/22/2004 | US20040141917 Antibodies to truncated VEGF-D and uses thereof |
| 07/22/2004 | US20040141915 Cancerous disease modifying antibodies |
| 07/22/2004 | US20040141914 Cancerous disease modifying antibodies |
| 07/22/2004 | US20040141913 Cancerous disease modifying antibodies |
| 07/22/2004 | DE10300335A1 Oxidoreduktase Oxidoreductase |
| 07/22/2004 | CA2507882A1 Transgenic mice expressing human cd20 |
| 07/22/2004 | CA2507880A1 Transgenic mice expressing human cd20 and/or cd16 |
| 07/21/2004 | EP1439229A2 Oncogene, recombinant protein derived therefrom, and uses thereof |
| 07/21/2004 | EP1439226A2 A nucleic acid antisense sequence to a polynucleotide encoding a polypeptide having heparanese activity |
| 07/21/2004 | EP1439193A2 Antibody directed to polypeptide having heparanase activity |
| 07/21/2004 | EP1439190A1 Growth differentiation factor-5 |
| 07/21/2004 | EP1438590A1 Article handling system and method |
| 07/21/2004 | EP1438562A2 Article dispensing apparatus and method |
| 07/21/2004 | EP1438561A2 Filtration system and method for obtaining a cytology layer |
| 07/21/2004 | EP1438559A2 Flow control metering system and method for controlling filtration of liquid-based specimens |
| 07/21/2004 | EP1438434A2 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 07/21/2004 | EP1438431A2 Methods for diagnosing and treating heart disease |
| 07/21/2004 | EP1438425A2 69583 and 85924,novel human protein kinase family members and uses therefor |
| 07/21/2004 | EP1438418A2 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| 07/21/2004 | EP1438411A2 Use of aminoglycoside resistance gene |
| 07/21/2004 | EP1438410A2 Promoters to control cell differentiation |
| 07/21/2004 | EP1438400A1 Multi-chain eukaryotic display vectors and uses thereof |
| 07/21/2004 | EP1438396A1 Gene transfer composition and method |
| 07/21/2004 | EP1438395A1 Growing xenotransplant material in culture |
| 07/21/2004 | EP1438394A1 Pig mast cell cultures and uses thereof |
| 07/21/2004 | EP1438393A1 Differentiation of whole bone marrow |
| 07/21/2004 | EP1438392A2 Cell populations which co-express cd49c and cd90 |
| 07/21/2004 | EP1438391A1 Mixture used to differentiate stem cells or neuronal progenitor cells in neuronal cells |
| 07/21/2004 | EP1438390A2 Circadian control of stem/progenitor cell self-renewal and differentiation and of clock controlled gene expression |
| 07/21/2004 | EP1438389A2 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer |
| 07/21/2004 | EP1438386A2 Transmembrane protein differentially expressed in cancer |
| 07/21/2004 | EP1438341A1 Antibody stimulating il-1ra production |
| 07/21/2004 | EP1438340A2 Antibodies against kdr, their production and uses |
| 07/21/2004 | EP1438339A2 Human antibodies that have mn binding and cell adhesion-neutralizing activity |
| 07/21/2004 | EP1438338A2 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof |
| 07/21/2004 | EP1438337A2 Crystals of cytochrome p450 2c9, structures thereof and their use |
| 07/21/2004 | EP1438331A1 A novel modulator of non-genonic activity of nuclear receptors (mnar) and uses thereof |
| 07/21/2004 | EP1438325A2 Isolated dna molecules encoding humanized calcitonin gene-related peptide receptor, related non-human transgenic animals and assay methods |
| 07/21/2004 | EP1438252A1 Container uncapping apparatus and method |
| 07/21/2004 | EP1438075A2 Methods and compositions relating to restricted expression lentiviral vectors and their applications |
| 07/21/2004 | EP1438068A2 Antibody inhibitors of gdf-8 and uses thereof |